Pronto disponible para inscripción
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.
SBT0000-01 - Clinical Trial
¿Cuál es el Propósito de este estudio?
Observational study.
¿Cuál es la Condición que se está estudiando?
A person can join this study if they have already received at least one dose of a Treg treatment in an earlier study.
¿Quién puede participar en el Estudio?
Must have completed the parent study.
Grupo etario
Adultos
¿Qué Implica?
This study is a Phase 4 observational study. It takes place at several medical centers. The goal is to check the long-term safety of people who have already received a special treatment made by Sonoma Biotherapeutics. This treatment uses gene-modified Treg cells. The study watches how these people do over time after receiving the treatment in an earlier study.
Detalles del Estudio
Título Completo
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Investigador Principal
Tarannum Jaleel, MD
Especialista en dermatología
Número de Protocolo
IRB:
PRO00119094
NCT:
NCT07123038
Fase
Phase IV
ClinicalTrials.gov
Ver en ClinicalTrials.gov
Estado de inscripción
Pronto disponible para inscripción